Therefore, our future research plan is to enlarge the sample size to confirm through NGS the association of the three significant genetic variants [HCG9 (rs3869062), GABBR1 (rs29232), and GSTM1 (+/DEL)] with NPC susceptibility. This evidence concerns the gene GSTM1 and nasopharyngeal carcinoma.